HealthDay News -- The medication rosiglitazone may slow the progression of eye disease in diabetes patients, according to new research from the Jules Stein Eye Institute at the University of California, Los Angeles.
HealthDay News -- The medication rosiglitazone may slow the progression of eye disease in diabetes patients, according to new research from the Jules Stein Eye Institute at the University of California, Los Angeles.
